In terms of HCC, as a submember of the TGF-β family, BMP4 was reported by Shen et al. to accelerate mesenchymal marker-induced oxaliplatin resistance via MEK/ERK/ELK1 signaling activation [43]. The gene discussed is MAPK1; the disease is hepatocellular carcinoma.